AKT1 and neoplasm: We presented here that Rac1 activity but not RhoA or Cdc42 was increased significantly by PA treatment through CD36-Src-Akt signaling pathway, suggesting that Rac1 participated in triggering actin-remodeling and promoting LUAD tumor metastasis (Fig. 5).